Nicholas Laccona

Companies

• Bellerophon Therapeutics (United States)Controller, (PFO & PAO) Oct 8, 2021 to Feb 14, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BTBellerophon Therapeutics (United States)12,470 shares²Dec 9, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2022Shares withheld for tax 5,530 shares at $0.93 of Bellerophon Therapeutics (United States)²
• Dec 9, 2022Exercised options 18,000 shares of Bellerophon Therapeutics (United States)²